Quick Answer
Petros Pharmaceuticals, Inc. reported Total Assets of $10.64 million for fiscal year 2024.
Petros Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $10.64M | -68.5% |
| 2023 | $33.80M | +4.2% |
| 2022 | $32.42M | -51.9% |
| 2021 | $67.39M | -3.5% |
| 2020 | $69.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.13M | -70.4% | -17.1% |
| June 30, 2025 | $7.40M | -70.6% | -58.0% |
| March 31, 2025 | $17.61M | -41.9% | +65.5% |
| December 31, 2024 | $10.64M | -68.5% | -48.6% |
| September 30, 2024 | $20.69M | -46.8% | -17.8% |
| June 30, 2024 | $25.17M | -12.4% | -17.0% |
| March 31, 2024 | $30.31M | -0.8% | -10.3% |
| December 31, 2023 | $33.80M | +4.2% | -13.2% |
- Petros Pharmaceuticals, Inc. showed a decrease of -68.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2024 period, Petros Pharmaceuticals, Inc.’s total assets has declined by 84.8% (from $69.85 million to $10.64 million).
- The most recent figure is from Petros Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: